Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB : Is one NUC better than the other? / G.L.-. Wong, P. Lampertico. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 71:3(2019 Sep), pp. 453-455.
Residual risk of HCC during long-term oral nucleos(t)ide analogues (NUCs) in patients with CHB : Is one NUC better than the other?
P. Lampertico
2019
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0168827819303034-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
298.15 kB
Formato
Adobe PDF
|
298.15 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
